Prestige Consumer Healthcare
PBH
279 hedge funds and large institutions have $2.92B invested in Prestige Consumer Healthcare in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 98 increasing their positions, 117 reducing their positions, and 25 closing their positions.
232% more call options, than puts
Call options by funds: $246K | Put options by funds: $74K
12% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 25
2.29% more ownership
Funds ownership: 100.52% → 102.81% (+2.3%)
0% more funds holding
Funds holding: 279 → 279 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $2.97B → $2.92B (-$50.5M)
16% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 117
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$97.2M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$10.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.23M |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$4.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$13.2M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$10.9M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.29M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$6.19M |
| 5 |
Man Group
London,
United Kingdom
|
-$5.86M |
PBH Hedge Fund Activity: Q3 2023 in Review
279 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2023, worth a combined $2.92B — down 1.7% from $2.97B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new PBH positions and 25 closed out — a net gain of 3 holders — while 98 added to existing stakes and 117 trimmed.
The largest buyer was Ariel Investments, adding an estimated $97.2M. The largest seller was BlackRock, cutting an estimated $13.2M.
- 279 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $2.92B of Prestige Consumer Healthcare stock for Q3 2023, down 1.7% quarter-over-quarter.
- 28 funds opened new Prestige Consumer Healthcare positions in Q3 2023 and 25 closed out, a net change of +3 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2023 was Ariel Investments, an estimated $97.2M added.
- The largest Prestige Consumer Healthcare seller in Q3 2023 was BlackRock, an estimated $13.2M sold.
Based on aggregated 13F filings for Q3 2023.